5:38pm PST - January 11th, 2023
A new genetic test developed at the #UniversityofHelsinki (@helsinkiuni0) and Helsinki University Hospital helps identify #ovariancancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer, said University of Helsinki. https://t.co/G037MCRlzg
0 retweets 1 likes - IANS (@ians_india)